ECOR-卫生主权：如何对欧洲流行病做出有力的应对（英文）-2020.7-44页_936kb

Summary: HEALTH SOVEREIGNTY: HOW TO BUILD A RESILIENT EUROPEAN RESPONSE TO PANDEMICS

Core Content

The document outlines the concept of health sovereignty as a critical component of national and European security, emphasizing the need for a coordinated and resilient European response to pandemics. It highlights the vulnerabilities of the EU in the face of global health crises, particularly the reliance on third countries for essential medical goods and services, which undermined the EU's ability to act autonomously.

The coronavirus pandemic has exposed the weaknesses of existing early warning systems, supply chain resilience, medical research and development, and cyber security and technology within the EU. These systems, which are vital for effective crisis management, have been criticized for their slow response and inadequate coordination during the initial outbreak.

Main Views

• Health is a security issue: The pandemic has demonstrated that health systems are as crucial to national security as defense and infrastructure. The lack of health security threatens societal stability, economic growth, and geopolitical standing.

• Global supply chain dependencies: The EU's dependence on China and India for critical medical supplies, such as masks and active pharmaceutical ingredients, has created vulnerabilities during the crisis. This has led to calls for reshoring and diversification of supply chains to ensure self-sufficiency.

• Need for European solidarity: Despite differences in national healthcare systems and policy approaches, there is a common demand for greater European coordination and solidarity to address the shortcomings of individual states and to protect the continent from external pressures.

• EU's role in health policy: While healthcare remains primarily a national competence, the EU has a vital role in coordinating responses, setting standards, and enhancing resilience through joint initiatives and strategic investments.

Key Information

Early Warning Systems

• The European Centre for Disease Prevention and Control (ECDC) and the Early Warning and Response System (EWRS) were established to monitor and respond to cross-border health threats.
• However, these systems were ineffective in early detection of the coronavirus, as the ECDC downplayed the risk and failed to provide timely alerts.
• The European Innovation Council (EIC) has initiated a project to develop an early warning system for infectious diseases, but it is still in the planning phase.

Supply Chain Resilience

• The EU is heavily dependent on China and India for medical supplies, which led to shortages and price hikes during the pandemic.
• The European Medicines Agency (EMA) has formed a taskforce to improve supply chain resilience, focusing on managing shortages and coordinating with industry and international partners.
• Member states have called for common strategic stocks and joint procurement to ensure equitable access to medical equipment and supplies.

Medical Research and Development

• The pandemic has accelerated medical R&D, with the goal of developing a vaccine within 18 months instead of the usual 10 years.
• The European Discovery clinical trial is comparing various antiviral treatments for severe cases of Covid-19.
• The EU has launched a global vaccine pledge to ensure equitable access to vaccines, raising €7.4 billion, but the US and China have not fully participated, raising concerns about their intentions.

Cyber Security and Technology

• The document notes that cyber security and technological infrastructure are essential for maintaining health data integrity and ensuring effective communication during crises.
• The pandemic has shown the importance of secure and reliable data networks in public health responses.

Recommendations

• Enhance early warning systems to improve detection and response to health threats.
• Diversify and reshore supply chains to reduce dependence on third countries.
• Invest in R&D and support innovative companies to strengthen the EU's capacity for medical breakthroughs.
• Promote European solidarity and coordination in international negotiations and resource allocation.
• Strengthen EU-level coordination in health policy to ensure a unified and effective response to future health emergencies.

Conclusion

The pandemic has exposed the fragility of Europe’s health systems and the importance of health sovereignty in a globalized world. While the EU cannot achieve full autarky, it can enhance its resilience and strategic independence through cooperation, investment, and solidarity. The document concludes that a pan-European approach is essential to protect public health in the face of growing geopolitical competition and future health crises.